Integrative Tumor Board: a case report and discussion from Dana-Farber Cancer Institute.
A 34-year-old woman carrying a BRCA1 gene and a significant family history was diagnosed with T1c, N1 breast cancer. The tumor was estrogen receptor, progesterone receptor, and HER-2/Neu negative. The patient received dose-dense chemotherapy with Adriamycin and Cytoxan followed by Taxol, and left breast irradiation. Later, a bilateral S-GAP flap reconstruction with right prophylactic mastectomy and left mastectomy were performed. During her treatment, the patient had an integrative medicine consultation and was seen by a team of health care providers specializing in integrative therapies, including integrative nutrition, therapeutic massage, acupuncture, and yoga. Each modality contributed unique benefit in her care that led to a satisfactory outcome for the patient. A detailed discussion regarding her care from each modality is presented. The case elucidates the need for integrative approaches for cancer patients in a conventional medical setting.
Lu
Weidong
W
Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Ott
Mary Jane
MJ
Kennedy
Stacy
S
Mathay
Maria B
MB
Doherty-Gilman
Anne M
AM
Dean-Clower
Elizabeth
E
Hayes
Carolyn M
CM
Rosenthal
David S
DS
D000047:Academies and Institutes; D015670:Acupuncture Therapy; D000328:Adult; D001007:Anxiety / Q000628:therapy; D019313:BRCA1 Protein / Q000235:genetics; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D000529:Complementary Therapies / Q000379:methods; D004035:Diet Therapy; D004358:Drug Therapy; D005260:Female; D006801:Humans; D055048:Integrative Medicine / Q000379:methods*; D008405:Massage; D008408:Mastectomy; D011788:Quality of Life; D011878:Radiotherapy; D013315:Stress, Psychological / Q000628:therapy; D015013:Yoga
D019313:BRCA1 Protein